A review on the molecular mechanisms, the therapeutic treatment including the potential of herbs and natural products, and target prediction of obesity-associated colorectal cancer
- 9 December 2021
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 175, 106031
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptorProceedings of the National Academy of Sciences, 2013
- Antiadipogenic Effects ofAster glehniExtract: In Vivo and In Vitro EffectsEvidence-Based Complementary and Alternative Medicine, 2013
- Traditional Medicine in China, Korea, and Japan: A Brief Introduction and ComparisonEvidence-Based Complementary and Alternative Medicine, 2012
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trialHepatology, 2011
- Crosstalk of reactive oxygen species and NF-κB signalingCell Research, 2010
- Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinaseMolecular Carcinogenesis, 2010
- Pitavastatin inhibits azoxymethane‐induced colonic preneoplastic lesions in C57BL/KsJ‐db/db obese miceCancer Science, 2010
- Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory SignalingToxicological Sciences, 2010
- Circulating Levels of Inflammatory Cytokines and Risk of Colorectal AdenomasCancer Research, 2008
- Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cellsLife Sciences, 2005